Mater Clinical Trials

Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health.  Clinical trials are an essential component of healthcare.  They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs. 

Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.

Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.

ABTECT-1 A study for people with moderately to severely active ulcerative colitis (UC)
Trial Status:
Active, not recruiting
|
Contact:
Sharyn Grossman
Enhancing treatment outcomes after after gynaecological cancer through exercise
Trial Status:
Not yet recruiting
|
Contact:
Dr Vivian Chiu
The purpose of the study is to test whether the addition of an immunotherapy drug, called tislelizumab, to the standard of care treatment of high-risk endometrial cancer reduces the risk of the disease coming back, and to determine if the new course of therapy is well-tolerated by participants.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
This study will investigate the use of a new medicine called AMT-151 which may be used in the future as a possible treatment for advanced solid tumours.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
The research study is testing a new way of taking hormone tablets for prostate cancer. The new method is called ‘adaptive therapy,’ also known as a pause/restart strategy.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
A Phase 1/2a Study Evaluating the Effects of ARO-RAGE Inhalation Solution in Healthy Subjects and Patients With Inflammatory Lung Disease
Trial Status:
Recruiting
|
Contact:
RIO Clinical Trials Unit
This study will investigate the use of a new medicine called sacituzumab govitecan (Trodelvy®) when compared to standard of care chemotherapy.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
This study will investigate the use of a new medicine called sacituzumab govitecan (Trodelvy®) combined with pembrolizumab when compared to standard of care chemotherapy.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
Feasibility of Electrical Impedance Tomography in assessing short-term effects of airway clearance techniques in adults with bronchiectasis, an observational study
Trial Status:
Not yet recruiting
|
Contact:
Judy Hough
The study is testing a new treatment for triple negative breast cancer. The new treatment includes four drugs called atezolizumab, bevacizumab, gemcitabine, and carboplatin.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
Displaying results 1-10 (of 71)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8  >  >|